ACPS: An accurate bioinformatics tool for precision-based anti-cancer peptide generation via omics data

Aman Chandra Kaushik1, Mengyang Li2, Aamir Mehmood3,4

  • 1Wuxi School of Medicine, Jiangnan University, Wuxi, China.

Insights

A new tool, the anti-cancer Scanner (ACPS), accurately identifies anti-cancer peptides. This bioinformatics tool offers over 95% accuracy for cancer research and drug design.

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Cancer Research

Background:

  • Anti-cancer targets are vital for cellular signaling but difficult to target without side effects.
  • Developing precise tools for identifying anti-cancer peptides is crucial for oncology and drug discovery.

Purpose of the Study:

  • To introduce the anti-cancer Scanner (ACPS), a novel bioinformatics tool for recognizing anti-cancer peptides.
  • To evaluate the performance of ACPS against existing tools and highlight its high accuracy.

Main Methods:

  • The ACPS tool was developed using the PERL programming language, extending the A-CaMP codebase.
  • ACPS scans protein sequences against anti-cancer target datasets to identify precision-based anti-cancer peptides.
  • Performance comparison with existing online tools was conducted to validate ACPS accuracy.

Main Results:

  • ACPS demonstrates a high accuracy rate exceeding 95%, surpassing existing tools.
  • The tool enables rapid fingerprinting of significant anti-cancer targets.
  • ACPS provides precision-based anti-cancer peptides from operator-supplied protein sequences.

Conclusions:

  • ACPS is a highly accurate and scalable tool for identifying anti-cancer peptides, significantly advancing bioinformatics in cancer research.
  • The tool's robust architecture and high performance offer substantial benefits for oncologists and researchers in structure-based drug design.
  • ACPS represents a valuable addition to the available resources for cancer biology and therapeutic development.

Related Concept Videos